Elevated Growth Differentiation Factor 15 Levels Predict Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation
Transcatheter aortic valve implantation (TAVI) has emerged as a treatment of aortic stenosis in patients at high surgicalrisk. However, risk stratification in this elderly population is challenging, as patients at extreme risk might not benefit from TAVI.